Marker Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MRKR and other ETFs, options, and stocks.About MRKR
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.
MRKR Key Statistics
Stock Snapshot
The current Marker Therapeutics(MRKR) stock price is $2.10, with a market capitalization of 35.51M. The stock trades at a price-to-earnings (P/E) ratio of -1.71.
On 2026-01-23, Marker Therapeutics(MRKR) stock moved within a range of $1.98 to $2.13. With shares now at $2.10, the stock is trading +6.0% above its intraday low and -1.4% below the session's peak.
Trading activity shows a volume of 221.08K, compared to an average daily volume of 586.55K.
The stock's 52-week range extends from a low of $0.81 to a high of $4.07.
The stock's 52-week range extends from a low of $0.81 to a high of $4.07.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.